Published on: 7 June 2022 Roche’s Vabysmo approved by Swissmedic as the first bispecific antibody for the eye to treat two leading causes of vision loss more
Published on: 10 January 2022 Roche’s Tecentriq approved by Swissmedic as adjuvant treatment for certain people with early non-small cell lung cancer more
Published on: 27 December 2021 Ronapreve approved by Swissmedic to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease more
Subscribe to Roche Media Releases for Switzerland Get the latest news and updates to your inbox. more
